Back to Search Start Over

Guideline for optimization of surgical and pathological quality performance for radical prostatectomy in prostate cancer management: evidentiary base.

Authors :
Chin JL
Srigley J
Mayhew LA
Rumble RB
Crossley C
Hunter A
Fleshner N
Bora B
McLeod R
McNair S
Langer B
Evans A
Source :
Canadian Urological Association journal = Journal de l'Association des urologues du Canada [Can Urol Assoc J] 2010 Feb; Vol. 4 (1), pp. 13-25.
Publication Year :
2010

Abstract

Background: The objective is to provide surgical and pathological guidelines for radical prostatectomy (RP) with or without concurrent pelvic lymph node dissection (PLND) to achieve optimal benefit for patients, with minimal risk of harm.<br />Methods: For surgical questions, a literature search of MEDLINE, EMBASE and the Cochrane database was performed. A literature search for the pathological questions was not conducted since the protocol for invasive carcinomas of the prostate gland developed by the College of American Pathologists (CAP) was endorsed. Urologists and pathologists were consulted for their assessment of the surgical and pathological recommendations.<br />Results: Limited high-quality evidence from 95 primary studies was available and, therefore, the expert panel developed recommendations on the basis of a consensus of the expert opinion of the working group and through a consultation with urologists and pathologists. In addition to the CAP protocol, some technical recommendations related to the handling and processing of the specimen were made.<br />Conclusion: Radical prostatectomy is recommended for the surgical treatment of prostate cancer, depending on a patient's preoperative risk profile. The panel unanimously determined that the goals for RP are to attain a positive margin rate of <25% for pT2 disease, a mortality rate of <1%, rates of rectal injury of <1% and blood transfusion rates of <10% in non-anemic patients. Standard PLND should be mandatory in high-risk patients, should be recommended for intermediate-risk patients and should be optional for low-risk patients. The quality and effectiveness of this treatment and of subsequent patient care depend on good management, effective communication and reporting between surgeons and pathologists working together as part of a multidisciplinary team. The complete guideline document is posted on the Cancer Care Ontario website (www.cancercare.on.ca); search in their Toolbox, Quality Guidelines & Standards, Clinical Program category under "surgery."

Details

Language :
English
ISSN :
1920-1214
Volume :
4
Issue :
1
Database :
MEDLINE
Journal :
Canadian Urological Association journal = Journal de l'Association des urologues du Canada
Publication Type :
Academic Journal
Accession number :
20165572
Full Text :
https://doi.org/10.5489/cuaj.08105